Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Candy

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Neuro-Oncology|October 22, 2013
miR-331-3p regulates expression of neuropilin-2 in glioblastomaMichael R Epis, Keith M Giles, Patrick A Candy, et al.
Physiotherapy|November 6, 2012
Effect of a high-density foam seating wedge on back pain intensity when used by 14 to 16-year-old school students: a randomised controlled trialElizabeth A Candy, Daniel Farewell, Christina Jerosch-Herold, et al.
Clinical Nuclear Medicine|February 1, 1985
Hepatobiliary-lung imaging. A case reportM M LaManna, A Candy, C N Boland, et al.
Plos One|November 2, 2012
Regulation of epidermal growth factor receptor signaling and erlotinib sensitivity in head and neck cancer cells by miR-7Felicity C Kalinowski, Keith M Giles, Patrick A Candy, et al.
Current Medical Research and Opinion|August 19, 2007
Clinical and economic impact of using macrogol 3350 plus electrolytes in an outpatient setting compared to enemas and suppositories and manual evacuation to treat paediatric faecal impaction based on actual clinical practice in England and WalesJulian F Guest, David C A Candy, John P Clegg, et al.
British Journal of Cancer|August 1, 2013
Notch-induced transcription factors are predictive of survival and 5-fluorouracil response in colorectal cancer patientsP A Candy, M R Phillips, A D Redfern, et al.
Oncotarget|September 15, 2017
miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progressionMichael R Epis, Keith M Giles, Dianne J Beveridge, et al.
Molecular Cancer Therapeutics|September 13, 2013
Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinibKeith M Giles, Felicity C Kalinowski, Patrick A Candy, et al.
Archives of Disease in Childhood. Education and Practice Edition|May 22, 2012
Assessment of childhood obesity in secondary care: OSCA consensus statementRussell M Viner, Billy White, Timothy Barrett, et al.
Oncotarget|May 21, 2016
microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κBKeith M Giles, Rikki A M Brown, Clarissa Ganda, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Neuro-Oncology|October 22, 2013
miR-331-3p regulates expression of neuropilin-2 in glioblastomaMichael R Epis, Keith M Giles, Patrick A Candy, et al.
Physiotherapy|November 6, 2012
Effect of a high-density foam seating wedge on back pain intensity when used by 14 to 16-year-old school students: a randomised controlled trialElizabeth A Candy, Daniel Farewell, Christina Jerosch-Herold, et al.
Clinical Nuclear Medicine|February 1, 1985
Hepatobiliary-lung imaging. A case reportM M LaManna, A Candy, C N Boland, et al.
Plos One|November 2, 2012
Regulation of epidermal growth factor receptor signaling and erlotinib sensitivity in head and neck cancer cells by miR-7Felicity C Kalinowski, Keith M Giles, Patrick A Candy, et al.
Current Medical Research and Opinion|August 19, 2007
Clinical and economic impact of using macrogol 3350 plus electrolytes in an outpatient setting compared to enemas and suppositories and manual evacuation to treat paediatric faecal impaction based on actual clinical practice in England and WalesJulian F Guest, David C A Candy, John P Clegg, et al.
British Journal of Cancer|August 1, 2013
Notch-induced transcription factors are predictive of survival and 5-fluorouracil response in colorectal cancer patientsP A Candy, M R Phillips, A D Redfern, et al.
Oncotarget|September 15, 2017
miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progressionMichael R Epis, Keith M Giles, Dianne J Beveridge, et al.
Molecular Cancer Therapeutics|September 13, 2013
Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinibKeith M Giles, Felicity C Kalinowski, Patrick A Candy, et al.
Archives of Disease in Childhood. Education and Practice Edition|May 22, 2012
Assessment of childhood obesity in secondary care: OSCA consensus statementRussell M Viner, Billy White, Timothy Barrett, et al.
Oncotarget|May 21, 2016
microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κBKeith M Giles, Rikki A M Brown, Clarissa Ganda, et al.
Pageof 3